000 01175 a2200361 4500
005 20250516070131.0
264 0 _c20120511
008 201205s 0 0 eng d
022 _a1750-7448
024 7 _a10.2217/imt.11.160
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Rui-Tao
245 0 0 _aTroVax(®) vaccine therapy for renal cell carcinoma.
_h[electronic resource]
260 _bImmunotherapy
_cJan 2012
300 _a27-42 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCarcinoma, Renal Cell
_ximmunology
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Active
_xmethods
650 0 4 _aKidney Neoplasms
_ximmunology
650 0 4 _aModels, Immunological
650 0 4 _aTreatment Outcome
650 0 4 _aVaccines, DNA
700 1 _aBines, Steven D
700 1 _aRuby, Carl
700 1 _aKaufman, Howard L
773 0 _tImmunotherapy
_gvol. 4
_gno. 1
_gp. 27-42
856 4 0 _uhttps://doi.org/10.2217/imt.11.160
_zAvailable from publisher's website
999 _c21373469
_d21373469